FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

11 Observations in Eugia Pharma Inspection

[ Price : $8.95]

FDA releases the form FDA-483 with 11 observations from an inspection at Indias Eugia Pharma Specialties sterile drug manufacturin...

Antimicrobial Drug Duration of Use Guidance

[ Price : $8.95]

FDA publishes a guidance with recommendations for how sponsors of animal drugs may facilitate changes to the approved conditions o...

Authorize Generic GLP-1s: Public Citizen

[ Price : $8.95]

Public Citizen petitions HHS to use existing law to eliminate patent barriers that prevent the entry of generic forms of Novo Nord...

Court Says Warning Letter Can be Final FDA Action

[ Price : $8.95]

Hyman, Phelps & McNamara attorney Peter Dickos reviews a Florida federal court decision that said FDA Warning Letters sent to Hybr...

CBER Head Overruled Staff on Moderna Flu Vaccine Filing

[ Price : $8.95]

CBER director Vinay Prasad overrules the Centers career reviewers in deciding to issue Moderna a refusal-to-file letter for its BL...

FDA Not Serious About Mifepristone Review: GOP Senators

[ Price : $8.95]

Politico says some GOP senators expressed frustration with FDA over a lack of apparent progress on its supposed safety review of t...

Issues with AI-Enhanced Surgical Devices Cited

[ Price : $8.95]

A detailed Reuters report looks at instances of surgical adverse events that may be related to artificial technology-enhanced medi...

FDA OKs Novocures Optune Pax for Advanced Pancreatic Cancer

[ Price : $8.95]

FDA approves Novocures Optune Pax for use in combination with gemcitabine and nab-paclitaxel for adults with locally advanced panc...

Inhaled Gene Therapy for Lung Cancer Gets Expedited Status

[ Price : $8.95]

FDA awards Krystal Biotech a Regenerative Medicine Advanced Therapy designation for KB707, an inhalable gene therapy being investi...

Keytruda Regimen for PD-L1Positive Ovarian Cancers Approved

[ Price : $8.95]

FDA approves Mercks Keytruda (pembrolizumab), as well as the fixed-dose combination pembrolizumab and berahyaluronidase alfa-pmph ...